Method to identify antigen-specific immune cells for therapeutic development
US9442113B1 · kind B1 · utility
1Cited by
4References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 17, 2016 |
| Grant date | Sep 13, 2016 |
| Priority date | — |
| Expiry date | Jun 17, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/56972
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
This disclosure is directed to methods for retrieving and using at least one lymphocyte. Additionally, cell receptor sequences identified with this strategy could be used for antibody development, TCR discovery, or appropriate therapeutics development or evaluation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.